SCHEMBL16236340

SCHEMBL16236340

Cc1[nH]c(C(=O)Nc2cc(Cl)c(F)c(Cl)c2)cc1S(=O)(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 4/20 0.43
▸ LPAR1 Q92633 1/20 0.41
▸ PLA2G7 Q13093 6/20 0.37
▸ MAPT P10636 2/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ POLB P06746 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ APOBEC3G Q9HC16 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236502 0.94 ENPP2 (0.40) ENPP2LPAR1PLA2G7MAPTKMT2A
SCHEMBL16237215 0.88 CYP1A2 (0.45) ENPP2LPAR1PLA2G7RXFP1NPC1
SCHEMBL16236925 0.85 CYP1A2 (0.36) ENPP2PLA2G7KMT2ARXFP1NPC1
SCHEMBL16236829 0.83 CYP1A2 (0.41) ENPP2LPAR1PLA2G7KMT2ARXFP1
SCHEMBL16237501 0.81 RAB9A (0.48) ENPP2PLA2G7MAPTKMT2ARXFP1
SCHEMBL16236610 0.80 NPC1 (0.49) PLA2G7MAPTKMT2ARXFP1NPC1
SCHEMBL16237050 0.79 PLA2G7 (0.37) PLA2G7
SCHEMBL16236351 0.78 PLA2G7 (0.43) PLA2G7RXFP1NPC1RAB9A
SCHEMBL16237029 0.77 CYP1A2 (0.41) PLA2G7MAPTKMT2ARXFP1NPC1
SCHEMBL16237209 0.77 PLA2G7 (0.45) PLA2G7KMT2ARXFP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997011-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Janssen Sciences Ireland UC (IE) 2016-03-23 — — EP disclosed
WO-2014184350-A1 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN R&D IRELAND (IE) 2014-11-20 — — WO disclosed
Send feedback